|
WCOG Scientific Program |
|
|
Time (IST) |
Topics |
|
08:45 - 09:00 |
Welcome |
|
09:00 - 10:00 |
Session: |
|
09:00 - 09:15 |
Managing GI Bleeding on Antiplatelets & Anticoagulants |
|
09:15 - 09:30 |
Topical Hemostatic Agents: How to Choose between Powders, Gels & Sealants |
|
09:30 - 09:45 |
GI Bleeding in the Intesive Care Unit |
|
09:45 - 10:00 |
Q&A |
|
10:00 - 11:00 |
Session: |
|
10:00 - 10:15 |
Holistic Management of Metabolic Dysfunction-Associated Steatotic Liver Disease |
|
10:15 - 10:30 |
Chronic Hepatitis B Virus (HBV): New Targets and Drugs |
|
10:30 - 10:45 |
Diagnosis and Management of Hepatocelular Carcinoma in 2026 |
|
10:45 - 11:00 |
Q&A |
|
11:00 - 11:30 |
Nutrition Break |
|
11:30 - 12:30 |
Session: |
|
11:30 - 11:45 |
What is new in Rome V |
|
11:45 - 12:00 |
Pharmacological & Non-Pharmacological Treatment of Functional Dyspepsia |
|
12:00 - 12:15 |
Post-Infectious Irritable Bowel Syndrome (PI- IBS): Epidemiology, Diagnosis & Treatment |
|
12:15 - 12:30 |
Q&A |
|
12:30 - 13:30 |
Session: |
|
12:30 - 12:45 |
Acute Severe Ulcerative Colitis: Saving the Colon with Timely Interventions |
|
12:45 - 13:00 |
Approach to Refractory IBD |
|
13:00 - 13:15 |
The Role of Endoscopy in IBD |
|
13:15 - 13:30 |
Q&A |
|
13:30 - 14:30 |
Lunch |
|
14:30 - 15:30 |
Session: |
|
14:30 - 14:45 |
Autoimmune Pancreatitis (Type 1, 2, 3): Dilemmas in Diagnosis and Management |
|
14:45 - 15:00 |
Hypertriglyceridemia Associated Acute Pancreatitis: Outcomes and Preventive Strategies |
|
15:00 - 15:15 |
Approach to a Pancreatic Mass |
|
15:15 - 15:30 |
Q&A |
|
15:30 - 16:30 |
Liver Failure: |
|
15:30 - 15:45 |
Acute Liver Failure (ALF): Current Management Strategies |
|
15:45 - 16:00 |
Acute-on-Chronic Liver Failure (ACLF): Prognosis and Management |
|
16:00 - 16:15 |
Advances and Challenges in Liver Transplantation |
|
16:15 - 16:30 |
Q&A |
|
16:30 - 17:00 |
Nutrition Break |
|
17:00 - 18:00 |
Chronic Diarrhea: |
|
17:00 - 17:15 |
Celiac Disease: Current and Emerging Tests for Diagnosis |
|
17:15 - 17:30 |
Small Intestinal Bacterial Overgrowth (SIBO) and Non-Celiac Enteropathies |
|
17:30 - 17:45 |
Cascade Approach to Chronic Diarrhea: WGO Guidelines |
|
17:45 - 18:00 |
Q&A |
|
18:00 |
Closing Remarks |
|
19:00 - 20:00 |
Inauguration |
|
20:00 Onwards |
Welcome Dinner |
|
WCOG Scientific Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Industry Breakfast Symposium 1 |
Industry Breakfast Symposium 2 |
Industry Breakfast Symposium 3 |
Breakfast Session |
Breakfast Session |
Breakfast Session |
|
|
09:00 - 10:00 |
Welcome and Orations |
||||||
|
Introductions |
|||||||
|
WGO - Henry L. Bockus Lecture |
|||||||
|
ISG-PN Chhuttani Oration |
|||||||
|
ISG - Presidential Oration |
|||||||
|
10:00 - 11:00 |
Session: |
||||||
|
10:00 - 10:15 |
Global Impact of GI and Liver Diseases |
||||||
|
10:15 - 10:30 |
Epidemiology of Digestive Cancer |
||||||
|
10:30 - 10:45 |
What Can Be Done to Change The Trends: Awareness, Education, Public Policy |
||||||
|
10:45 - 11:00 |
Q&A / Panel Discussion |
||||||
|
11:00 - 11:15 |
Nutrition Break |
||||||
|
11:15 - 12:15 |
Session: |
Session: |
Session |
Session: |
Session: |
Session: |
Free Papers |
|
11:15 - 11:30 |
How to Perform a Standardized Upper GI Endoscopy |
Functional Dyspepsia or Gastroparesis |
Pathophysiology of MASLD: Dissecting the Metabolic Dysfunction |
Understanding Pathophysiology of AP: How the Evidence Evolved |
IBD's Global Footprint: Were Are We Now? |
The Climate Change Crisis |
|
|
11:30 - 11:45 |
Quality Indicators in Colonoscopy: What Really Matters |
Choosing and Interpreting The Investigations |
Screening and Risk Stratification in MASLD |
From Acinar Injury to Organ Dysfunction: How does it Happen in Humans? |
Modifiying the Milieu: Enviromental Triggers You Can Control |
Impact of Climate Change on Vulnerable Populations |
|
|
11:45 - 12:00 |
ERCP Quality Matrix |
Pharmacological and Non-Pharmacological Treatment |
Pharmacotherapy in MASLD: How to Choose a Drug? |
Organ Failure in Acute Pancreatitis: Current and Future Treatment Strategies |
Eating for Remission: Evidence-Based Dietary Protocols in Practice |
Approaches to Greening Endoscopy |
|
|
12:00 - 12:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
|
12:15 - 12:30 |
Colorectal Cancer Screening: Strategies in Resource Limited Settings |
Esophageal Ambulatory pH-Impedancemetry |
Hepatitis A and E: Current Situation and New Developments |
COX 2 Inhibitors in AP |
Starting Strong: The First-Line Advanced Therapy Choice in UC |
State of the Art: Microbiome and Gut Health |
|
|
12:30 - 12:45 |
Risk Assessment of Polyps and Colorectal Cancer |
Laryngo-Pharyngeal Reflux |
Hepatitis B Guidelines: How Best to Apply them in Varied Resourced Settings |
Pancreatitis Associated with Systemic Diseases |
Bio-Naive vs Bio Experienced Patient with Moderate to Severe CD: A Differential Strategy |
||
|
12:45 - 13:00 |
Emerging Non-invasive Biomarkers for Colorectal Cancer Screening |
Treatment with Acid Suppression Including PCABs |
Challenges in the Global Elimination of Hepatitis C |
Can We Prevent Pancreatic Necrosis and Vascular Complications in AP |
The Era of Dual Therapy: Is Two Better Than One? |
State of the Art: Helicobacter Pylori Eradication Therapy to Prevent Gastric Cancer |
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:15 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Industry Lunch Symposium 1 |
Industry Lunch Symposium 2 |
Industry Lunch Symposium 3 |
Lunch Session |
Lunch Session |
Lunch Session |
||
|
14:45 - 15:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
|
14:45 - 15:00 |
Indeterminate Biliary Stricture: Current Standards & New Tools |
Investigations |
Non-Invasive Tests for MetALD and Alcohol Related Liver Disease |
Optimizing Fluid Management: Approaches Within and After 48 Hours |
Healing the Hidden: A Multidisciplinary Approach to Fistulizing Disease |
Adult Education |
|
|
15:00 - 15:30 |
Management of Malignant Hilar Obstruction |
Pharmacological and Non-Pharmacological Treatment |
Next-Gen Therapies for Alcoholic Hepatitis: Regeneration, Barrier Repair and Precision Immunology |
Managing Pain in AP |
Providing Effective Feedback |
||
|
15:15 - 15:30 |
ERCP in Altered Anatomy: Strategy & Troubleshooting |
Global Guidelines |
Liver Transplantion in Alcohol Related Liver Disease |
International Association of Pancreatology Guidelines on Management of AP |
Pouch Preservation: Managing the Refractory Patient |
Presentation Skills |
|
|
15:30 - 15:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
15:45 - 16:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
|
15:45 - 16:00 |
Gastric Varices: Best Practices in 2026 |
Neuropsychological Issues in DGBI |
Management of Non-Responders to First Line Treatment in Autoimmune Hepatitis |
Diagnosis of Infected Pancreatic Necrosis |
The Surgeon's Edge: Timing is Everything |
Small Group Facilitation |
|
|
16:00 - 16:15 |
Liver Biopsy: EUS vs Percutaneous vs Transjugular |
Chronic Intestinal Pseudo-Obstruction |
New Therapies for Primary Biliary Cholangitis |
Current Therapeutic Strategies to Manage Infected Necrotizing Pancreatitis |
The Second Act: Preventing the Return of Crohn's |
Bedside Teaching |
|
|
16:15 - 16:30 |
EUS-Guided Portal Vein Access & Emerging Applications |
Approach to Fecal Incontinence |
Future Treatment Options for Primary Sclerosing Cholangitis |
Impact and Treatment of MDR XDR Infection in Acute Necrotizing Pancreatitis |
The Crohn's Stricture Toolkit: Balancing Medical, Endoscopic and Surgical Intervention |
Teaching a Skill |
|
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
16:45 - 17:00 |
Nutrition Break |
||||||
|
17:00 - 18:00 |
Session: |
Panel Discussions |
Session: |
Session: |
Session: |
Free Papers |
Free Papers |
|
17:00 - 17:15 |
Endoscopic Closure of Leaks & Fistulae: Clips to Suturing - A Stepwise Approach |
Overlap Disorders of Gut-Brain Interaction |
Novel Biomarkers and Pathways in DILI: From Mechanistic Insights to Clinical Translation |
Psychological / Behavioural Issues and Their Management in Chronic Pancreatitis |
More Than A Gut Feeling: Bones, Joints, and IBD |
||
|
17:15 - 17:30 |
Regenerative Endoscopy & Tissue Healing Strategies |
DILI from CAM: Public Health impact, Evidence Gaps, and Medico-Legal Challenges |
Fatty Pancreas: Summary of An International Multidisciplinary Consensus |
Preventing Vascular and Hematologic Complications |
|||
|
17:30 - 17:45 |
EndoVAC Therapy: Indications, Technique & Optimization |
Achalasia and POEM |
Immune-Mediated Liver Injury from Check-point Inhibitors (ILICI) |
Genetics of Recurrent Acute and Chronic Pancreatitis: Guidance for Clinicians |
Uninvited Guests: Identifying and Managing Opportunistic Infections in IBD |
||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
18:00 - 19:00 |
Endoscopy - Free Paper |
Luminal - Free Papers |
Hepatology - Free Papers |
Pancreas - Free Papers |
Free Papers |
Free Papers |
Free Papers |
|
19:00 |
Adjourn |
||||||
|
19:00 Onwards |
Networking & Banquet Dinner |
||||||
|
WCOG Scientific Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Industry Breakfast |
Industry Breakfast |
Industry Breakfast |
Breakfast Session |
Breakfast Session |
Breakfast Session |
|
|
09:00 - 10:00 |
Orations 2 |
||||||
|
09:00 - 09:15 |
Introductions |
||||||
|
09:15 - 09:30 |
WGO - George Brohee Lecture |
||||||
|
09:30 - 09:45 |
INASL - Dr DV Datta Memorial Oration |
||||||
|
09:45 - 10:00 |
INASL - Presidential Oration |
||||||
|
10:00 - 11:00 |
Session: |
||||||
|
11:00 - 11:15 |
Nutrition Break |
||||||
|
11:15 - 12:15 |
INASL Orations |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
|
11:15 - 11:30 |
Introductions |
Global Epidemiology of H. Pyori Infections and Implications for Public Health |
Difficult CBD Stones: Modern Endoscopic Solutions |
Redefining IBD Monitoring with Ultrasound |
Early Chronic Pancreatitis: Is the Process Reversible? |
What are the Barriers for a Female Gastroenterologist and How We Can Change Them? |
|
|
11:30 - 11:45 |
Dr SR Naik Memorial Oration |
Diagnosis of H. Pylori: When and How Test for Hp |
Pre-operative Biliary Drainage: When & How |
Improving Clinical Decisions with Modern Endoscopic Tools |
RK Tandon Oration |
Gastroenterology Training: Challenges and Opportunities for Women |
|
|
11:45 - 12:00 |
Dr N Madanagopalan Oration |
Treatment of H. pylori in 2026 |
Endoscopic Management of PSC |
Artificial Intelligence in IBD: Impact on Outcomes |
Advancing into Leadership Roles |
||
|
12:00 - 12:15 |
BN Tandon Memorial Oration |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
|
12:15 - 12:30 |
Assessment of Clinically Significant Portal Hypertension (CSPH) |
Shifts in Gastric Cancer Epidemiology and its Implications Worldwide |
Best Techniques for EUS-Guided Tissue Acquisition |
From Lab to Clinic: Harnessing Microbiota for Healing |
Pancreatic Neuroendocrine Tumours (NET) |
The Burden of Burnout in Health Care |
|
|
12:30 - 12:45 |
Beyond Beta-Blockers: Emerging Therapies and Anticoagulation Strategies |
Enhancing Detection of Early Gastric Cancer in Resource Constrained Settings |
Approach to the Incidental Pancreatic Cyst |
The Youngest Patients: Unravelling VEO-IBD |
IPMN and Pancreatic Cystic Neoplasms: Summary of Guidelines from Biology to Precision Surgery |
Strategies to Improve Wellbeing |
|
|
12:45 - 13:00 |
Clinical Outcomes After Recompensation |
Diagnosis and Management of Atrophic Gastritis and Intestinal Metaplasia |
EUS Approach to Gallbladder Disorders |
Precision IBD: Transition from One-Size-Fits-All to Patient-Centric Care |
Precision Medicine in Pancreatic Cancer |
Communication Skills and Difficult Conversation |
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
13:15 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Industry Lunch Symposium |
Industry Lunch Symposium |
Industry Lunch Symposium |
Lunch Session |
Lunch Session |
Lunch Session |
||
|
14:45 - 15:45 |
Session: |
Session: |
Live Endoscopy |
Session: |
Session: |
Free Papers |
|
|
14:45 - 15:00 |
Treatment Options for Refractory Ascites |
Global Epidemiology of Celiac Disease and Future Projections |
More Than a Diagnosis: Living well with IBD |
Developing a Chemotherapeutic Molecule for Pancreatic Cancer: Lessons from a Personal Journey |
|||
|
15:00 - 15:15 |
Long-Term Albumin for Decompensated Cirrhosis |
Breaking Free: Treatments for Celiac Disease Beyond Gluten-Free Diet |
Stopping the Spark: The Future of IBD Prevention |
Mechanisms of Pancreatic Cancer Cachexia: Tumor-Immune Crosstalk |
|||
|
15:15 - 15:30 |
Current and Future Management of HRS-AKI |
Increasing the Detection of Celiac Disease Globally: Opportunities and Challenges |
Intercepting the Disease: Strategies for Secondary Prevention |
Radiomics and AI in Pancreatic Cancer |
|||
|
15:30 - 15:45 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
15:45 - 16:45 |
Session: |
Session: |
Live Endoscopy |
Session: |
Session: |
Free Papers |
|
|
15:45 - 16:00 |
Pathophysiology of Hepatic Encephalopathy: Beyond Ammonia |
Secretory Diarrhea: An Investigative Approach |
Latest Guidelines for Pregnancy and IBD |
Metabolic Red Flags: New onset Diabetes, Sarcopenia and Unexplained Weight Loss as Predictors |
|||
|
16:00 - 16:15 |
New Diagnostic Tools and Biomarkers in Hepatic Encephalopathy |
Global Burden of GI Parasitic Infection: Impact on Human Health in the 21st Century |
CCFI Guidelines for IBD: Sequencing Therapy Crohn Disease |
Prehabilitation Before Surgery for Pancreatic Cancer |
|||
|
16:15 - 16:30 |
Minimal Hepatic Encephalopathy (MHE): Diagnosis, |
Tuberculosis Related Digestive Diseases |
Sequencing Therapy Ulcerative Colitis |
Surgery for Oligometastatic Pancreatic Cancer |
|||
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
16:45 - 17:00 |
Nutrition Break |
Nutrition Break |
|||||
|
17:00 - 18:00 |
Session: |
Session: |
Session: |
IBD - Free Papers |
Free Papers |
Free Papers |
Free Papers |
|
17:00 - 17:15 |
New Strategies for Surveillance for HCC in Cirrhosis |
Beyond Short Bowel Syndrome |
Metabolic Endoscopy: Beyond Weight Loss |
||||
|
17:15 - 17:30 |
Staging and Decision Making for Treatment in HCC |
Assessment of Intestinal Failure |
Endoscopic Gastric Remodeling Techniques |
||||
|
17:30 - 17:45 |
Managing Unresectable HCC - Emerging Options |
Short and Long Term Treatment Options |
Role of GLP-1 Therapy in Bariatric Endoscopy |
||||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
||||
|
18:00 - 19:00 |
Session: |
Session: |
Session: |
Editor's Corner - How to Get Published |
Free Papers |
Free Papers |
|
|
18:00 - 18:15 |
Current and Emerging Concepts in Diagnosis and Management of PSVD/NCPF |
Eating Disorders |
Corrosive Strictures: Endoscopic Strategies |
Increasing Your Changes of Acceptance |
|||
|
18:15 - 18:30 |
Management of Budd Chiari Syndrome: Current status and Dilemmas |
Impact of Ultra-Processed Food |
Esophageal Stenting: Indications & Techniques |
TBD |
|||
|
18:30 - 18:45 |
Management of Portal Vein Thrombosis is Cirrhosis |
FODMAP Diet for DGBI |
Barrett's Esophagus: Diagnosis and Management |
Use of AI in Research and Publications ? |
|||
|
18:45 - 19:00 |
Q&A |
Q&A |
Q&A |
Panel Discussion / Q&A |
|||
|
19:00 - 19:30 |
Break for Dinner and Evening Symposium |
||||||
|
19:30 - 20:30 |
Session: |
Session: |
Session: |
Industry Dinner Symposium |
Industry Dinner Symposium |
Industry Dinner Symposium |
Industry Dinner Symposium |
|
19:30 - 19:45 |
Medical Therapies |
Referral for Liver Transplantation: When is it Too Early and Late? |
|||||
|
19:45 - 20:00 |
Endoscopic Treatments |
Immunosuppressive Strategies in Liver Transplantation: Tricks of the Trade |
|||||
|
20:00 - 20:15 |
Surgical Approaches |
Early Allograft Dysfunction After Liver Transplantation |
|||||
|
20:15 - 20:30 |
Panel Discussion / Q&A |
Panel Discussion / Q&A |
Panel Discussion / Q&A |
||||
|
20:30 |
Adjourn |
||||||
|
20:30 |
Dinner |
||||||
|
WCOG Scientific Program |
|||||||
|
Time (IST) |
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
|
08:00 - 09:00 |
Industry Breakfast |
Industry Breakfast |
Industry Breakfast |
Breakfast Session |
Breakfast Session |
Breakfast Session |
|
|
09:00 - 10:00 |
Orations 5 |
||||||
|
09:00 - 09:15 |
Introductions |
||||||
|
09:15 - 09:30 |
ISG - CM Habibullah Oration |
||||||
|
09:30 - 09:45 |
IPC - Presidential Oration |
||||||
|
09:45 - 10:00 |
INMA Oration |
||||||
|
10:00 - 11:00 |
Presidential Plenary - Best Free Papers |
||||||
|
11:00 - 11:30 |
Nutrition Break |
||||||
|
11:30 - 12:30 |
Session: |
Session: |
Session: |
Session: |
Session: |
Free Papers |
Free Papers |
|
11:30 - 11:45 |
Esophageal Disorders |
Cerebral Edema and Intracranial Pressure Monitoring in ALF |
EUS Guided Biliary Drainage |
The AI Gastroenterologist: A Chimera or the New Normal in the Evolving Era of Digestive Healthcare |
Pediatric Acute Pancreatitis: Special Challenges |
||
|
11:45 - 12:00 |
Gastroduodenal Disorders |
Infections in ALF: Assessment, Prevention, Management |
Disconnected Pancreatic Duct Syndrome: Diagnosis to Therapy |
Beyond the Buzzwords: Where AI Is Already Changing GI Practice |
Drug-induced Pancreatitis: Truth or Myth |
||
|
12:00 - 12:15 |
Bowel and Anorectal Disorders |
Novel Strategies to Improve Outcomes in ALF |
Ampullectomy: Tricks of the Trade |
Artificial Inteligence in Endoscopy: Current Evidence, Clinical Utility and Implementation Pathways |
Chronic Pancreatitis and Type 3c Diabetes: Mechanisms and Special Considerations For Management |
||
|
12:15 - 12:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
12:30 - 13:30 |
ISG - BSG Symposium |
Session: |
Session: |
Session: |
Session: |
Free Papers |
Free Papers |
|
12:30 - 12:45 |
ACLF Endotypes and Trajectories: Toward Global Harmonization and Precision Trials |
POEM and GERD: New Evidence and Evolving Concepts |
Trust, Risk, and Regulation: How to Approve AI for Real Patients |
Timing of Cholecystectomy in Severe Acute Pancreatitis |
|||
|
12:45 - 13:00 |
Ammonia as a Biomarker in Cirrhosis and ACLF |
G-POEM: Selecting the Right Responders |
AI in Endoscopy Training: Promises and Threats, AI in Endoscopy Training |
Early Diagnosis and Biomarkers of Gallbladder Cancer |
|||
|
13:00 - 13:15 |
Advances in Extracorporeal Liver Systems for ACLF |
Robotic Endoscopy: Are We Ready for Prime Time? |
AI in Hepatology - Revolutionizing the Diagnosis and Management |
Incidental Gallbladder Cancer After Cholecystectomy: Approach to Management |
|||
|
13:15 - 13:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:30 - 14:45 |
Lunch and Poster Viewing |
||||||
|
Liver Clinics: Case Based Discussions |
Industry Lunch Symposium |
Industry Lunch Symposium |
Industry Lunch Symposium |
Lunch Session |
Lunch Session |
Lunch Session |
|
|
14:45 - 16:00 |
Orations 6 |
Session: |
Free Papers |
Free Papers |
Free Papers |
||
|
14:45 - 15:00 |
Introductions |
Recent Advances in the Endovascular Management of HCC |
|||||
|
15:00 - 15:15 |
CCFI Oration - IBD |
Prophylactic and Pre-emptive TIPS: Overtreatment or Survival Advantage? |
|||||
|
15:15 - 15:30 |
INMA Oration - Neuro GI |
Role of IR in Vascular Emergencies in Cirrhosis |
|||||
|
15:30 - 15:45 |
WGO - Trailblazer Award |
Q&A |
|||||
|
15:45 - 16:00 |
Masters of WGO |
||||||
|
16:00 - 17:00 |
Closing Ceremonies |
||||||
Indian Society of Gastroenterology (ISG)
402, 4th Floor, Surya Kiran Building,
Kasturba Gandhi Marg, New Delhi – 110001
World Gastroenterology Organisation (WGO)
E: info@worldgastroenterology.org
Elisyan India Pvt. Ltd.
M: +91 99714 18591
E: secretariat@wcog2026india.com
©Copyright WCOG 2026 India. All Rights Reserved